Akèy › Kansè lestomak › Texas › Tyler
Etid klinik pou Kansè lestomak nan Tyler, TX
4 etid pou Kansè lestomak ap chèche patisipan nan sit nan ak bò kote Tyler (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
Ap rekriteFaz 3
- Texas Oncology, P.A. - Tyler, Tyler
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Ap rekriteFaz 1/2
- Texas Oncology, Tyler
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Ap rekriteFaz 1/2
- The University of Texas Health Science Center at Tyler, Tyler
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Ap rekriteFaz 1
- UT Health East Texas HOPE Cancer Center, Tyler
- UT Health East Texas Hope Cancer Center, Tyler
Etid Kansè lestomak nan lòt vil
- Houston, TX42 etid
- Boston, MA32 etid
- New York City, NY31 etid
- Nashville, TN28 etid
- Los Angeles, CA22 etid
- Baldwin Park, CA22 etid
- Arlington, VA20 etid
- Dallas, TX19 etid
- San Antonio, TX19 etid
- Grand Rapids, MI18 etid
- St. Louis, MO18 etid
- Washington, DC16 etid
Lòt etid nan Tyler
- Kansè Poumon ki pa ti selil20 etid
- Maladi Crohn16 etid
- Kolit Ulseratif14 etid
- Kansè kolorektal8 etid
- Ensifizyans kadyak8 etid
- Kansè (tout kalite)7 etid
- Kansè ovè7 etid
- Kansè Endomèt6 etid
- Karsinòm selil skuamèz tèt ak kou6 etid
- Kansè nan tete6 etid
- Kansè Metastatik5 etid
- Maladi Entestinal Anflamatwa5 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.